BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37157128)

  • 1. Meibomian Gland Dysfunction in Primary Acquired Nasolacrimal Duct Obstruction.
    Yoon S; Lee H; Baek S
    J Craniofac Surg; 2023 Jun; 34(4):e395-e398. PubMed ID: 37157128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the meibomian glands in postmenopausal women with primary acquired nasolacrimal duct obstruction: a prospective study.
    Jin H; Zhang H
    BMC Ophthalmol; 2023 Feb; 23(1):48. PubMed ID: 36726065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tear instability in the fellow eye of unilateral nasolacrimal obstruction and resolution with dacryocystorhinostomy.
    Tıskaoğlu NS; Yazıcı A
    Orbit; 2023 Aug; 42(4):404-410. PubMed ID: 36069079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced tear break-up time in the fellow eye of patients with unilateral primary acquired nasolacrimal duct obstruction.
    Tıskaoğlu NS; Yazıcı A
    Int Ophthalmol; 2023 Mar; 43(3):965-971. PubMed ID: 36053478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective controlled study of vapor pressure tear osmolality and tear meniscus height in nasolacrimal duct obstruction.
    Stahl U; Francis IC; Stapleton F
    Am J Ophthalmol; 2006 Jun; 141(6):1051-6. PubMed ID: 16765672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dry Eye Assessment of Patients Undergoing Endoscopic Dacryocystorhinostomy for Nasolacrimal Duct Obstruction Combined with Dry Eye Syndrome.
    Kim MH; Lee K; Chang M
    Korean J Ophthalmol; 2023 Oct; 37(5):395-400. PubMed ID: 37621092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher incidence of meibomian gland dysfunction in postmenopausal women with primary acquired nasolacrimal duct obstruction.
    Wang G; Jin H; Sheng Y; Ji F; Liu Y; Han L; Wang X; Chen X; Ding H; Liu J; Fu Q
    Int Ophthalmol; 2024 Feb; 44(1):70. PubMed ID: 38349418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lacrimal gland activity in lacrimal drainage obstruction: exploring the potential cross-talk between the tear secretion and outflow.
    Singh S; Srivastav S; Bothra N; Paulsen F; Ali MJ
    Br J Ophthalmol; 2024 Mar; 108(4):621-624. PubMed ID: 37142331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Videoreflective dacryomeniscometry in normal adults and in patients with functional or primary acquired nasolacrimal duct obstruction.
    Francis IC; Chan DG; Papalkar D; Papas EB; Stapleton F
    Am J Ophthalmol; 2005 Mar; 139(3):493-7. PubMed ID: 15767059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lacrimal Gland Volume Changes in Unilateral Primary Acquired Nasolacrimal Obstruction.
    Yazici A; Bulbul E; Yazici H; Sari E; Tiskaoglu N; Yanik B; Ermis S
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4425-9. PubMed ID: 26193918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dry eye and decreased tear film stability in primary acquired nasolacrimal duct obstruction patients.
    Yu X; Wang K; Hu Y; Meng Z; Li J; Liu Y; Xiao L; Chen M; Li S; Shen Y; Chen R; Liang X
    Int Ophthalmol; 2024 Jun; 44(1):277. PubMed ID: 38916702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tear meniscus measurement in nasolacrimal duct obstruction patients with Fourier-domain optical coherence tomography: novel three-point capture method.
    Park DI; Lew H; Lee SY
    Acta Ophthalmol; 2012 Dec; 90(8):783-7. PubMed ID: 21726426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tear-Film Osmolarity Changes Following Dacryocystorhinostomy in Primary Acquired Nasolacrimal Duct Obstruction.
    Yuksel N; Akcay E; Ayan B; Duru N
    Curr Eye Res; 2017 Mar; 42(3):348-350. PubMed ID: 27419611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcanalicular endoscopic dacryoplasty in patients with primary acquired nasolacrimal duct obstruction.
    Lee SM; Lew H
    Graefes Arch Clin Exp Ophthalmol; 2021 Jan; 259(1):173-180. PubMed ID: 32743774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of Tear Cytokine Expressions in Primary Acquired Nasolacrimal Duct Obstruction - Potential Insights into the Etiopathogenesis.
    Ali MJ; Patnaik S; Kelkar N; Ali MH; Kaur I
    Curr Eye Res; 2020 Apr; 45(4):435-439. PubMed ID: 31490706
    [No Abstract]   [Full Text] [Related]  

  • 16. Matrix Metalloproteinase-9 Point-of-Care Immunoassay after Dacryocystorhinostomy in Patients with Nasolacrimal Duct Obstruction.
    Woo SE; Jang SY
    Semin Ophthalmol; 2021 Apr; 36(3):128-131. PubMed ID: 33641609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple technique of meibography for morphological and functional evaluation of meibomian glands in dry eye conditions.
    Mounika V; Kamath SJ; Tejaswi P; Kamath AR; Rodrigues GR; Mendonca TM
    Indian J Ophthalmol; 2023 Apr; 71(4):1420-1425. PubMed ID: 37026275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meibomian Gland Dysfunction in Patients With Chemotherapy-Induced Lacrimal Drainage Obstruction.
    Eom Y; Baek S; Kim HM; Song JS
    Cornea; 2017 May; 36(5):572-577. PubMed ID: 28257384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Tear Film Lipid Layer Thickness Measurements Obtained Using an Ocular Surface Interferometer in Nasolacrimal Duct Obstruction Patients.
    Lee SM; Chung SJ; Lew H
    Korean J Ophthalmol; 2018 Dec; 32(6):445-450. PubMed ID: 30549467
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.